The pain therapy market is valued at $44.3 billion growing at 14.9% annually. Product categories like anti-rheumatic NSAIDs, topical anti-rheumatics, anti-osteoporosis preparations, and anti-arthritic drugs are growing faster than the overall market. Specifically, Aceclofenac + Paracetamol, Thiocolchicosides + Combinations, Etodolac, and Ademethionine combinations as well as topical preparations are seeing substantial growth within the segment. Aceclofenac + Paracetamol is well accepted for its safety profile and is prescribed by all medical specialties.